CAMO Symposium 2026 | Re-defining Cancer Survivorship: From Treatment to Thriving
Conference Venue: The Brownstone
Venue Address: 221 10 AV SE, Suite #120, Calgary, AB, T2G 0V9
Directions: Google Maps Link
Event Landscape
As more patients live longer after cancer, oncologists are increasingly challenged to address long-term toxicities, quality of life, and survivorship care in everyday practice.
Co-chaired by Dr. Scott Berry, Dr. Stephen Welch, and Dr. Christine Brezden-Masley in collaboration with CAMO and WINC-ALINC, this symposium will highlight modern survivorship care, chronic toxicities, psychosocial wellbeing, AYA perspectives, and emerging models of care across Canada.
Through expert-led presentations and a dynamic, audience‑driven panel discussion, participants will gain practical insights they can bring back to their clinics immediately.
Learning Objectives
- Summarize the most significant treatment advances presented at the 2026 ASCO® Annual Meeting
- Review of the current standard of care for key malignancies.
- Discuss current controversies in the management of specific cancers.
Scientific Agenda
Click below to learn more about the scheduled presentations and incredible speaker lineup
Event Co-Chairs
Scott Berry
BSc, MD, MHSc, FRCPC
Dr. Scott Berry is a medical oncologist and Chief and Medical Director of the Oncology Program at Trillium Health Partners in Mississauga. He is the regional vice-president for Cancer Care Ontario – Ontario Health’s Mississauga Halton Central West Regional Cancer Program and an Adjunct Professor of Oncology at Queen’s University. Dr. Berry’s clinical specialty is gastrointestinal cancer. He is a past Chair of the Gastrointestinal Disease Site Group of the Cancer Ontario Program in Evidence Based Care. Dr. Berry is a medical educator who is Co-Director of Education for the Queen’s Global Oncology Program and has previously served as Chair of the Royal College of Physicians and Surgeons of Canada Specialty Committee for Medical Oncology. He is one of the co-founders of OncologyEducation.com. His other academic interest is the bioethical issues surrounding the care of people with cancer, including the ethical issues related to equitable access to cancer medications. He is a former member and ethics advisor to the pan-Canadian Oncology Drug Review Expert Review Committee and has served on the ASCO Ethics Committee.
Stephen Welch
MD, FRCPC
Associate Professor, Department of Oncology, Western University
Staff Medical Oncologist, London Regional Cancer Program, London Health Sciences Centre.
Dr. Stephen Welch joined the Department of Oncology and the Division of Medical Oncology in London, Ontario in September 2007. Currently, he is the Chair of the Division of Medical Oncology. Dr. Welch received undergraduate medicine and internal medicine credentials at the University of Manitoba and subsequently trained as a resident in medical oncology at Western University and as a clinical research fellow in oncology early phase clinical trials at the Princess Margaret Hospital in Toronto.
Christine Brezden-Masley
MD, PhD, FRCPC
Christine Brezden-Masley, MD PhD FRCPC is a senior practicing Medical Oncologist and the Medical Director of the Cancer Program at Sinai Health System in Toronto, Canada. She is also the Director of the Marvelle Koffler Breast Centre at Sinai Health and holds the Marvelle Koffler Chair in Breast Research. She obtained her PhD in Medical Biophysics at the Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is a Professor at the Temerty Faculty of Medicine, University of Toronto and an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, Toronto, Canada. She treats both breast and gastrointestinal (colorectal and gastric cancers) malignancies, which are her major areas of research interest. Her main area of clinical research is cardiotoxicity from cancer therapy and is the Past-President of the Canadian Cardio-Oncology Network (2017-2022). She also serves on the International CardioOncology Society (ICOS) annual summit steering committees and co-chaired the 2022 Global Cardio-Oncology Summit in Toronto. She co-chairs the Junior Mentoring Program JuMP that fosters mentorship/sponsorship of junior medical oncology faculty across Canada and serves on the executive of WinC (Women in Cancer/All in Cancer). She is an advocate for patients and serves as a board member of ReThink Breast Cancer and MyGutFeeling and also serves on the scientific committee for the Colorectal Cancer Resource & Action Network.
Sponsorship
For sponsorship-related inquiries, please contact your Director of Strategic Partnerships or visit our website at https://www.oncologyeducation.com/about-us/improving-patient-care-through-oncology-education/.
Conference Sponsors
Silver sponsor
Bronze sponsor
Please note mdBriefCase Group Inc. O/A Oncology Education cannot provide visa support for event attendees, including letters of invitation. Event attendees are solely responsible for obtaining any necessary documentation required for travel and participation in the event. No refunds shall be provided to individuals who are unable to attend.